Skip to main content
Top
Published in: Hepatology International 2/2010

01-06-2010 | Original Article

Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then

Authors: Mehnaaz Sultan Khuroo, Mohammad Sultan Khuroo

Published in: Hepatology International | Issue 2/2010

Login to get access

Abstract

Purpose

Large-scale waterborne epidemics of hepatitis E occur in developing countries. It is not known why these epidemics occur repeatedly and selectively in adult population?

Methods

We studied seroepidemiology of an outbreak of hepatitis E in one of 15 villages that had recorded first epidemic of hepatitis E 30 years back. Another village not affected by the second epidemic was taken as a control. Overall, 1,216 sera were collected (638 from the epidemic village and 578 from the control village) for serological markers of both hepatitis A virus (HAV) and hepatitis E virus (HEV).

Results

The seroprevalence of anti-HEV in this population following the first epidemic in 1978 was 29.4%. Antibodies were detected in only 47% of the 45 patients affected by icteric HEV infection 14 years after the first epidemic. At 30-year follow-up, the seroprevalence of anti-HEV was only 4.5% (26/578). In the village affected by second epidemic, 138 (21.6%) subjects had serological evidence of recent HEV infection. The attack rate was 23.6% (78/330) in children (≤14 years) and 19.4% (60/308) in adults (P = 0.21). The attack rate of anicteric HEV infection was 21.8% (72/330) in children and 14.6% (45/308) in adults (P = 0.02).

Conclusions

Following hepatitis E epidemics, there is a gradual loss of antibodies in the community over the decades and poor exposure to HEV infection in the cohort of population born during the interepidemic period. The next epidemic occurs when antibody levels fall to critically low levels and there is associated gross fecal contamination of water resources. During epidemic, persons of all age groups are exposed to infection, with predominant anicteric disease in children.
Literature
1.
go back to reference Khuroo MS. Study of an epidemic of non-A, non-B hepatitis: possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980;68:818–824CrossRefPubMed Khuroo MS. Study of an epidemic of non-A, non-B hepatitis: possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980;68:818–824CrossRefPubMed
2.
go back to reference Wong DC, Purcell RH, Sreenivason MA, Prasad SR, Pavri KM. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus etiology. Lancet 1980;2:882–885 Wong DC, Purcell RH, Sreenivason MA, Prasad SR, Pavri KM. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus etiology. Lancet 1980;2:882–885
3.
go back to reference Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983;20(1):23–31CrossRefPubMed Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983;20(1):23–31CrossRefPubMed
4.
go back to reference Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990;247(4948):1335–1339CrossRefPubMed Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990;247(4948):1335–1339CrossRefPubMed
5.
go back to reference Mushahwar IK. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 2008;80(4):646–658CrossRefPubMed Mushahwar IK. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 2008;80(4):646–658CrossRefPubMed
8.
go back to reference Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981;70:252–255CrossRefPubMed Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981;70:252–255CrossRefPubMed
9.
go back to reference Khuroo MS, Kamili S. Etiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003;10:61–69CrossRefPubMed Khuroo MS, Kamili S. Etiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003;10:61–69CrossRefPubMed
10.
go back to reference Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007;147(1):28–33PubMed Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007;147(1):28–33PubMed
11.
go back to reference Khuroo MS, Kamili S. Association of severity of hepatitis E virus infection in the mother and vertically transmitted infection in the fetus. JK Pract 2006;13:70–74 Khuroo MS, Kamili S. Association of severity of hepatitis E virus infection in the mother and vertically transmitted infection in the fetus. JK Pract 2006;13:70–74
12.
go back to reference Khuroo MS, Khuroo N. Hepatitis E: global epidemiology with special reference to impact of the disease in India and the Southeast of Asia. In Rizzetto M, Purcell RH, Gerin JL, Vernie G, editors. Viral Hepatitis and Liver Disease. Turin: Edizioni Minerva Medica; 1997. 601–608 Khuroo MS, Khuroo N. Hepatitis E: global epidemiology with special reference to impact of the disease in India and the Southeast of Asia. In Rizzetto M, Purcell RH, Gerin JL, Vernie G, editors. Viral Hepatitis and Liver Disease. Turin: Edizioni Minerva Medica; 1997. 601–608
13.
go back to reference Skidmore SJ, Yarbough PO, Gabor KA, Reyes GR. Hepatitis E virus: the cause of a waterborne hepatitis outbreak. J Med Virol 1992;37:58–60CrossRefPubMed Skidmore SJ, Yarbough PO, Gabor KA, Reyes GR. Hepatitis E virus: the cause of a waterborne hepatitis outbreak. J Med Virol 1992;37:58–60CrossRefPubMed
14.
go back to reference Kamili S, Khuroo MS, Jameel S. Hepatitis E: Studies on Transmission, Etiological Agent and Sero-epidemiology. PhD thesis. Srinagar: University of Kashmir; 1994 Kamili S, Khuroo MS, Jameel S. Hepatitis E: Studies on Transmission, Etiological Agent and Sero-epidemiology. PhD thesis. Srinagar: University of Kashmir; 1994
15.
go back to reference Khuroo MS, Saleem M, Teli MR, Sofi MA. Failure to detect chronic liver disease after epidemic non-A, non-B hepatitis (letter). Lancet 1980;2:97–98CrossRefPubMed Khuroo MS, Saleem M, Teli MR, Sofi MA. Failure to detect chronic liver disease after epidemic non-A, non-B hepatitis (letter). Lancet 1980;2:97–98CrossRefPubMed
16.
go back to reference Khuroo MS, Jameel S, Kamili S, Moecklii R, Dar MY. Hepatitis E and long term antibody status (letter). Lancet 1993;341:1355PubMed Khuroo MS, Jameel S, Kamili S, Moecklii R, Dar MY. Hepatitis E and long term antibody status (letter). Lancet 1993;341:1355PubMed
17.
go back to reference Fix AD, Abdel-Hamid M, Purcell RH, et al. Prevalence of antibodies to hepatitis E virus in rural Egyptian communities. Am J Trop Med Hyg 2000;62:519–523 Fix AD, Abdel-Hamid M, Purcell RH, et al. Prevalence of antibodies to hepatitis E virus in rural Egyptian communities. Am J Trop Med Hyg 2000;62:519–523
18.
go back to reference Arankalle VA, Tsarev SA, Chada MS, et al. Age specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis 1995;171:447–450PubMed Arankalle VA, Tsarev SA, Chada MS, et al. Age specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis 1995;171:447–450PubMed
19.
go back to reference Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007;356:895–903CrossRefPubMed Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007;356:895–903CrossRefPubMed
20.
Metadata
Title
Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then
Authors
Mehnaaz Sultan Khuroo
Mohammad Sultan Khuroo
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Hepatology International / Issue 2/2010
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-009-9159-5

Other articles of this Issue 2/2010

Hepatology International 2/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.